A Year in Review: 2015 505(b)(2) NDA Approvals
Camargo recently published a thorough review of the 2015 505(b)(2) NDA approvals. There are a lot of interesting statistics to glean...
2015 Novel New Drug Summary
The FDA recently released their 2015 Novel New Drug Summary. While CDER will approve hundreds of new medications each year, many of...
Ichthyosis Clinic at Massachusetts General Now Open
Specialty adult and pediatric ichthyosis clinic at Massachusetts General Hospital is now open. For more details, please direct yourself...
FRAME Ichthyosis: A collaboration between the FIRST community and the Positive Exposure organization
FIRST, in collaboration with Positive Exposure, released a great video this week that highlights congenital ichthyosis from the patient...
Worldwide orphan drug sales forecast to total $178bn in 2020
EvaluatePharma has just released their Orphan Drug Report 2015. This free report contains tons of great information on the current state...
FDA Case Study - Drug Approval: Bringing a New Drug to the Market
FDA is introducing a new learning tool for patients and patient advocacy groups, health professionals, small business, and pharmaceutical...
Global Orphan Drug Market to Gain Almost $68 Billion by 2019
BCC Research recently released a new research report highlighting the global orphan drug market. With a forecasted compound annual...
FDA Comments on Recently Released Rare Disease Guidance for Industry
Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on...
Patagonia team attending the Bourne Partners Global Healthcare Executive Summit next week!
We're excited to attend the fifth annual Bourne Partners Global Healthcare Executive Summit in Charlotte, North Carolina on September...
Who is the Foundation for Ichthyosis and Related Skin Types (FIRST)?
We talk about the FIRST organization quite a bit here at Patagonia. They are an incredible resource for patients and supporters. To...
